Appendix Adenocarcinoma
3 clinical trials · Condition
◉ Watch Appendix Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Genetics of Appendix Cancer Study (NCT05734430) | Andreana Holowatyj, PhD, MSCI | 2022-11-11 |
| Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors (NCT03108131) | M.D. Anderson Cancer Center | 2017-04-07 |
| Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors (NCT03074513) | M.D. Anderson Cancer Center | 2017-03-03 |
Track Appendix Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.